Glatiramer acetate does not protect from acute ischemic stroke in mice

BACKGROUND: The role of the immune system in the pathophysiology of acute ischemic stroke is increasingly recognized. However, targeted treatment strategies to modulate immunological pathways in stroke are still lacking. Glatiramer acetate is a multifaceted immunomodulator approved for the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Kraft, Peter, Göbel, Kerstin, Meuth, Sven G, Kleinschnitz, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943273/
https://www.ncbi.nlm.nih.gov/pubmed/24576335
http://dx.doi.org/10.1186/2040-7378-6-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943273/
https://www.ncbi.nlm.nih.gov/pubmed/24576335
http://dx.doi.org/10.1186/2040-7378-6-4

Ejemplares similares